Avricore Health (AVCRF) EBITDA Margin Growth (1y) (2010 - 2026)
Avricore Health (AVCRF) EBITDA Margin Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 50.00 |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 519.00 |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 136.00 |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 376.00 |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | -101.00 |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 235.00 |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 93.00 |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 352.00 |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | -78.00 |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6,202.70 | 110,589.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 110,589.00 |
| Sep 30, 2025 | -100,752.00 |
| Jun 30, 2025 | -166,177.00 |
| Mar 31, 2025 | -3,158.00 |
| Sep 30, 2024 | 2,464.00 |
| Jun 30, 2024 | 6,164.00 |
| Mar 31, 2024 | -280.00 |
| Dec 31, 2023 | 2,950.00 |
| Sep 30, 2023 | 223.00 |
| Jun 30, 2023 | 6,728.00 |
| Mar 31, 2023 | 9,582.00 |
| Dec 31, 2022 | 13,681.00 |
| Sep 30, 2022 | 1,090.00 |
| Jun 30, 2022 | 87,199.00 |
| Mar 31, 2022 | 58,033.00 |
| Dec 31, 2021 | 22,053.00 |
| Sep 30, 2021 | 16,426.00 |
| Jun 30, 2021 | -66,922.00 |
| Mar 31, 2021 | -29,365.00 |
| Dec 31, 2020 | 193,507.00 |